Professor Ian Meredith to join Boston Scientific
Professor Meredith currently serves as professor of Medicine and Cardiology for Monash University, Director of MonashHeart and Monash Health and as executive director of the Monash Cardiovascular Research Centre in Melbourne, Australia.
He brings to Boston Scientific more than 25 years of experience as a clinical and interventional cardiologist.
Professor Meredith has performed more than 10,000 invasive cardiac and coronary procedures, published more than 300 manuscripts and has been chief or principal investigator on 30 major international multi-center trials, including first-in-man trials of new drug-eluting stents.
Professor Meredith's work has focused on the development and clinical evaluation of devices for the treatment of coronary artery and structural heart disease, and he has been at the forefront of emerging percutaneous cardiac valve therapies.
He was also the global principal investigator for the Boston Scientific Lotus Valve REPRISE research program.
Professor Meredith received undergraduate and doctorate degrees from Monash University in Melbourne, Australia.
He trained in Melbourne and completed his Ph.D. at the Baker Institute before spending three years at the Brigham & Women's Hospital and Harvard Medical School in Boston.
He will succeed Executive Vice President and Global Chief Medical Officer Keith Dawkins, M.D., who has announced his intention to retire from the company in January 2017. ■
What to read next
LATEST MOVES FROM Massachusetts
- Chiasma re-appoints Roni Mamluk to board
- BayCoast Bank appoints James Wallace as CFO
- Pulmatrix appoints Amit D. Munshi to board
- Syros Pharmaceuticals appoints Srinivas Akkaraju to board
- Merrimack Pharma names Sergio Santillana as CMO
More inside POST